nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Carglumic Acid—Vigabatrin—epilepsy syndrome	0.254	1	CrCrCtD
Acetylcysteine—GRIN2A—epilepsy syndrome	0.142	0.541	CbGaD
Acetylcysteine—GRIN2B—epilepsy syndrome	0.121	0.46	CbGaD
Acetylcysteine—GRIN2A—Felbamate—epilepsy syndrome	0.0988	0.357	CbGbCtD
Acetylcysteine—GRIN2B—Felbamate—epilepsy syndrome	0.0988	0.357	CbGbCtD
Acetylcysteine—GRIN3A—Felbamate—epilepsy syndrome	0.0656	0.237	CbGbCtD
Acetylcysteine—SLC22A6—Acetazolamide—epilepsy syndrome	0.00783	0.0283	CbGbCtD
Acetylcysteine—SLC22A6—Valproic Acid—epilepsy syndrome	0.00585	0.0211	CbGbCtD
Acetylcysteine—GRIN1—telencephalic ventricle—epilepsy syndrome	0.00213	0.0509	CbGeAlD
Acetylcysteine—GRIN2B—telencephalic ventricle—epilepsy syndrome	0.00203	0.0485	CbGeAlD
Acetylcysteine—GRIN1—ganglion—epilepsy syndrome	0.00132	0.0317	CbGeAlD
Acetylcysteine—GRIN2B—ganglion—epilepsy syndrome	0.00126	0.0302	CbGeAlD
Acetylcysteine—SLC7A11—tongue—epilepsy syndrome	0.00118	0.0282	CbGeAlD
Acetylcysteine—GRIN2D—hindbrain—epilepsy syndrome	0.00113	0.0269	CbGeAlD
Acetylcysteine—GRIN2A—ganglion—epilepsy syndrome	0.0011	0.0264	CbGeAlD
Acetylcysteine—Pyruvic acid—ABAT—epilepsy syndrome	0.00107	1	CrCbGaD
Acetylcysteine—GRIN1—hindbrain—epilepsy syndrome	0.001	0.024	CbGeAlD
Acetylcysteine—GSS—ganglion—epilepsy syndrome	0.000966	0.0231	CbGeAlD
Acetylcysteine—GRIN2B—hindbrain—epilepsy syndrome	0.000958	0.0229	CbGeAlD
Acetylcysteine—GRIN2A—hindbrain—epilepsy syndrome	0.000838	0.02	CbGeAlD
Acetylcysteine—GRIN2D—brainstem—epilepsy syndrome	0.000646	0.0154	CbGeAlD
Acetylcysteine—GRIN2D—forebrain—epilepsy syndrome	0.000623	0.0149	CbGeAlD
Acetylcysteine—GRIN3A—forebrain—epilepsy syndrome	0.000586	0.014	CbGeAlD
Acetylcysteine—GRIN1—brainstem—epilepsy syndrome	0.000576	0.0138	CbGeAlD
Acetylcysteine—GRIN2D—telencephalon—epilepsy syndrome	0.000573	0.0137	CbGeAlD
Acetylcysteine—GRIN1—forebrain—epilepsy syndrome	0.000556	0.0133	CbGeAlD
Acetylcysteine—GRIN2B—brainstem—epilepsy syndrome	0.000549	0.0131	CbGeAlD
Acetylcysteine—GRIN3A—telencephalon—epilepsy syndrome	0.000539	0.0129	CbGeAlD
Acetylcysteine—GRIN2B—forebrain—epilepsy syndrome	0.00053	0.0127	CbGeAlD
Acetylcysteine—GRIN1—telencephalon—epilepsy syndrome	0.000511	0.0122	CbGeAlD
Acetylcysteine—ACY1—head—epilepsy syndrome	0.000504	0.012	CbGeAlD
Acetylcysteine—SLC7A11—forebrain—epilepsy syndrome	0.0005	0.012	CbGeAlD
Acetylcysteine—GRIN2B—telencephalon—epilepsy syndrome	0.000487	0.0117	CbGeAlD
Acetylcysteine—GRIN2A—brainstem—epilepsy syndrome	0.00048	0.0115	CbGeAlD
Acetylcysteine—ACY1—nervous system—epilepsy syndrome	0.000478	0.0114	CbGeAlD
Acetylcysteine—GRIN2A—forebrain—epilepsy syndrome	0.000463	0.0111	CbGeAlD
Acetylcysteine—SLC7A11—telencephalon—epilepsy syndrome	0.00046	0.011	CbGeAlD
Acetylcysteine—ACY1—central nervous system—epilepsy syndrome	0.00046	0.011	CbGeAlD
Acetylcysteine—GRIN2D—medulla oblongata—epilepsy syndrome	0.00045	0.0108	CbGeAlD
Acetylcysteine—ACY1—cerebellum—epilepsy syndrome	0.00045	0.0107	CbGeAlD
Acetylcysteine—GRIN2A—telencephalon—epilepsy syndrome	0.000426	0.0102	CbGeAlD
Acetylcysteine—GSS—brainstem—epilepsy syndrome	0.00042	0.01	CbGeAlD
Acetylcysteine—GSS—forebrain—epilepsy syndrome	0.000405	0.00969	CbGeAlD
Acetylcysteine—GRIN2D—spinal cord—epilepsy syndrome	0.000402	0.0096	CbGeAlD
Acetylcysteine—IKBKB—telencephalon—epilepsy syndrome	0.00038	0.00908	CbGeAlD
Acetylcysteine—GSS—telencephalon—epilepsy syndrome	0.000373	0.00891	CbGeAlD
Acetylcysteine—GRIN1—midbrain—epilepsy syndrome	0.000367	0.00877	CbGeAlD
Acetylcysteine—ACY1—brain—epilepsy syndrome	0.000365	0.00873	CbGeAlD
Acetylcysteine—GRIN1—spinal cord—epilepsy syndrome	0.000358	0.00856	CbGeAlD
Acetylcysteine—GRIN2D—head—epilepsy syndrome	0.000357	0.00853	CbGeAlD
Acetylcysteine—CHUK—head—epilepsy syndrome	0.000348	0.00832	CbGeAlD
Acetylcysteine—GRIN2B—spinal cord—epilepsy syndrome	0.000342	0.00816	CbGeAlD
Acetylcysteine—GRIN2D—nervous system—epilepsy syndrome	0.000338	0.00809	CbGeAlD
Acetylcysteine—GRIN3A—head—epilepsy syndrome	0.000336	0.00802	CbGeAlD
Acetylcysteine—GRIN2A—medulla oblongata—epilepsy syndrome	0.000335	0.008	CbGeAlD
Acetylcysteine—SLC7A11—midbrain—epilepsy syndrome	0.00033	0.0079	CbGeAlD
Acetylcysteine—GRIN2D—central nervous system—epilepsy syndrome	0.000326	0.00779	CbGeAlD
Acetylcysteine—SLC7A11—spinal cord—epilepsy syndrome	0.000322	0.0077	CbGeAlD
Acetylcysteine—GRIN2D—cerebellum—epilepsy syndrome	0.000318	0.00761	CbGeAlD
Acetylcysteine—GRIN3A—nervous system—epilepsy syndrome	0.000318	0.00761	CbGeAlD
Acetylcysteine—GRIN1—head—epilepsy syndrome	0.000318	0.00761	CbGeAlD
Acetylcysteine—CHUK—cerebellum—epilepsy syndrome	0.00031	0.00742	CbGeAlD
Acetylcysteine—GRIN3A—central nervous system—epilepsy syndrome	0.000306	0.00732	CbGeAlD
Acetylcysteine—GRIN2A—midbrain—epilepsy syndrome	0.000306	0.00731	CbGeAlD
Acetylcysteine—GRIN2B—head—epilepsy syndrome	0.000304	0.00726	CbGeAlD
Acetylcysteine—GRIN1—nervous system—epilepsy syndrome	0.000302	0.00721	CbGeAlD
Acetylcysteine—GRIN2A—spinal cord—epilepsy syndrome	0.000299	0.00714	CbGeAlD
Acetylcysteine—GSS—medulla oblongata—epilepsy syndrome	0.000293	0.007	CbGeAlD
Acetylcysteine—GRIN1—central nervous system—epilepsy syndrome	0.00029	0.00694	CbGeAlD
Acetylcysteine—GRIN2B—nervous system—epilepsy syndrome	0.000288	0.00688	CbGeAlD
Acetylcysteine—SLC7A11—head—epilepsy syndrome	0.000286	0.00685	CbGeAlD
Acetylcysteine—GRIN1—cerebellum—epilepsy syndrome	0.000284	0.00679	CbGeAlD
Acetylcysteine—GRIN2B—central nervous system—epilepsy syndrome	0.000277	0.00662	CbGeAlD
Acetylcysteine—SLC7A11—nervous system—epilepsy syndrome	0.000272	0.00649	CbGeAlD
Acetylcysteine—GRIN2B—cerebellum—epilepsy syndrome	0.000271	0.00647	CbGeAlD
Acetylcysteine—GSS—midbrain—epilepsy syndrome	0.000268	0.0064	CbGeAlD
Acetylcysteine—GRIN2A—head—epilepsy syndrome	0.000265	0.00634	CbGeAlD
Acetylcysteine—SLC7A11—central nervous system—epilepsy syndrome	0.000261	0.00625	CbGeAlD
Acetylcysteine—GSS—spinal cord—epilepsy syndrome	0.000261	0.00624	CbGeAlD
Acetylcysteine—GRIN2D—brain—epilepsy syndrome	0.000259	0.00618	CbGeAlD
Acetylcysteine—SLC7A11—cerebellum—epilepsy syndrome	0.000256	0.00611	CbGeAlD
Acetylcysteine—CHUK—brain—epilepsy syndrome	0.000252	0.00603	CbGeAlD
Acetylcysteine—GRIN2A—nervous system—epilepsy syndrome	0.000252	0.00601	CbGeAlD
Acetylcysteine—GRIN3A—brain—epilepsy syndrome	0.000243	0.00581	CbGeAlD
Acetylcysteine—GRIN2A—central nervous system—epilepsy syndrome	0.000242	0.00579	CbGeAlD
Acetylcysteine—GRIN2A—cerebellum—epilepsy syndrome	0.000237	0.00566	CbGeAlD
Acetylcysteine—IKBKB—head—epilepsy syndrome	0.000236	0.00565	CbGeAlD
Acetylcysteine—GSS—head—epilepsy syndrome	0.000232	0.00555	CbGeAlD
Acetylcysteine—GRIN1—brain—epilepsy syndrome	0.000231	0.00551	CbGeAlD
Acetylcysteine—IKBKB—nervous system—epilepsy syndrome	0.000224	0.00536	CbGeAlD
Acetylcysteine—GSS—nervous system—epilepsy syndrome	0.00022	0.00526	CbGeAlD
Acetylcysteine—GRIN2B—brain—epilepsy syndrome	0.00022	0.00526	CbGeAlD
Acetylcysteine—IKBKB—central nervous system—epilepsy syndrome	0.000216	0.00516	CbGeAlD
Acetylcysteine—GSS—central nervous system—epilepsy syndrome	0.000212	0.00506	CbGeAlD
Acetylcysteine—IKBKB—cerebellum—epilepsy syndrome	0.000211	0.00504	CbGeAlD
Acetylcysteine—SLC7A11—brain—epilepsy syndrome	0.000208	0.00496	CbGeAlD
Acetylcysteine—GSS—cerebellum—epilepsy syndrome	0.000207	0.00495	CbGeAlD
Acetylcysteine—GRIN2A—brain—epilepsy syndrome	0.000192	0.0046	CbGeAlD
Acetylcysteine—IKBKB—brain—epilepsy syndrome	0.000171	0.0041	CbGeAlD
Acetylcysteine—GSS—brain—epilepsy syndrome	0.000168	0.00402	CbGeAlD
Acetylcysteine—SLC22A6—brain—epilepsy syndrome	0.00016	0.00384	CbGeAlD
Acetylcysteine—Urticaria—Fosphenytoin—epilepsy syndrome	7.52e-05	0.000948	CcSEcCtD
Acetylcysteine—Nausea—Lacosamide—epilepsy syndrome	7.5e-05	0.000946	CcSEcCtD
Acetylcysteine—Body temperature increased—Fosphenytoin—epilepsy syndrome	7.48e-05	0.000944	CcSEcCtD
Acetylcysteine—Shock—Lamotrigine—epilepsy syndrome	7.48e-05	0.000943	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	7.43e-05	0.000937	CcSEcCtD
Acetylcysteine—Tachycardia—Lamotrigine—epilepsy syndrome	7.42e-05	0.000935	CcSEcCtD
Acetylcysteine—Asthma—Topiramate—epilepsy syndrome	7.41e-05	0.000934	CcSEcCtD
Acetylcysteine—Dyspnoea—Clonazepam—epilepsy syndrome	7.39e-05	0.000933	CcSEcCtD
Acetylcysteine—Somnolence—Clonazepam—epilepsy syndrome	7.37e-05	0.00093	CcSEcCtD
Acetylcysteine—Hypotension—Carbamazepine—epilepsy syndrome	7.35e-05	0.000927	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Lamotrigine—epilepsy syndrome	7.35e-05	0.000927	CcSEcCtD
Acetylcysteine—Dyspnoea—Phenytoin—epilepsy syndrome	7.34e-05	0.000926	CcSEcCtD
Acetylcysteine—Urticaria—Vigabatrin—epilepsy syndrome	7.33e-05	0.000924	CcSEcCtD
Acetylcysteine—Somnolence—Phenytoin—epilepsy syndrome	7.32e-05	0.000924	CcSEcCtD
Acetylcysteine—Hypersensitivity—Midazolam—epilepsy syndrome	7.32e-05	0.000923	CcSEcCtD
Acetylcysteine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	7.3e-05	0.000921	CcSEcCtD
Acetylcysteine—Dyspepsia—Clonazepam—epilepsy syndrome	7.3e-05	0.000921	CcSEcCtD
Acetylcysteine—Body temperature increased—Vigabatrin—epilepsy syndrome	7.29e-05	0.00092	CcSEcCtD
Acetylcysteine—Somnolence—Oxcarbazepine—epilepsy syndrome	7.28e-05	0.000919	CcSEcCtD
Acetylcysteine—Nausea—Clobazam—epilepsy syndrome	7.28e-05	0.000919	CcSEcCtD
Acetylcysteine—Dyspepsia—Phenytoin—epilepsy syndrome	7.25e-05	0.000915	CcSEcCtD
Acetylcysteine—Dizziness—Acetazolamide—epilepsy syndrome	7.23e-05	0.000911	CcSEcCtD
Acetylcysteine—Hypersensitivity—Levetiracetam—epilepsy syndrome	7.22e-05	0.000911	CcSEcCtD
Acetylcysteine—Urticaria—Diazepam—epilepsy syndrome	7.21e-05	0.00091	CcSEcCtD
Acetylcysteine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	7.21e-05	0.00091	CcSEcCtD
Acetylcysteine—Pruritus—Propofol—epilepsy syndrome	7.18e-05	0.000906	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	7.16e-05	0.000903	CcSEcCtD
Acetylcysteine—Cardiac disorder—Pregabalin—epilepsy syndrome	7.13e-05	0.0009	CcSEcCtD
Acetylcysteine—Flushing—Pregabalin—epilepsy syndrome	7.13e-05	0.0009	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	7.11e-05	0.000897	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	7.07e-05	0.000892	CcSEcCtD
Acetylcysteine—Pruritus—Midazolam—epilepsy syndrome	7.03e-05	0.000886	CcSEcCtD
Acetylcysteine—Dyspnoea—Carbamazepine—epilepsy syndrome	7.01e-05	0.000884	CcSEcCtD
Acetylcysteine—Pharyngitis—Gabapentin—epilepsy syndrome	6.99e-05	0.000882	CcSEcCtD
Acetylcysteine—Somnolence—Carbamazepine—epilepsy syndrome	6.99e-05	0.000882	CcSEcCtD
Acetylcysteine—Urticaria—Felbamate—epilepsy syndrome	6.98e-05	0.000881	CcSEcCtD
Acetylcysteine—Angiopathy—Pregabalin—epilepsy syndrome	6.97e-05	0.000879	CcSEcCtD
Acetylcysteine—Body temperature increased—Felbamate—epilepsy syndrome	6.95e-05	0.000877	CcSEcCtD
Acetylcysteine—Vomiting—Acetazolamide—epilepsy syndrome	6.95e-05	0.000876	CcSEcCtD
Acetylcysteine—Immune system disorder—Pregabalin—epilepsy syndrome	6.94e-05	0.000875	CcSEcCtD
Acetylcysteine—Pruritus—Levetiracetam—epilepsy syndrome	6.94e-05	0.000875	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Pregabalin—epilepsy syndrome	6.92e-05	0.000874	CcSEcCtD
Acetylcysteine—Dyspepsia—Carbamazepine—epilepsy syndrome	6.92e-05	0.000873	CcSEcCtD
Acetylcysteine—Urticaria—Zonisamide—epilepsy syndrome	6.84e-05	0.000862	CcSEcCtD
Acetylcysteine—Body temperature increased—Zonisamide—epilepsy syndrome	6.8e-05	0.000858	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vigabatrin—epilepsy syndrome	6.8e-05	0.000857	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	6.79e-05	0.000856	CcSEcCtD
Acetylcysteine—Dyspnoea—Lamotrigine—epilepsy syndrome	6.77e-05	0.000855	CcSEcCtD
Acetylcysteine—Angioedema—Valproic Acid—epilepsy syndrome	6.76e-05	0.000853	CcSEcCtD
Acetylcysteine—Somnolence—Lamotrigine—epilepsy syndrome	6.76e-05	0.000852	CcSEcCtD
Acetylcysteine—Dizziness—Propofol—epilepsy syndrome	6.71e-05	0.000847	CcSEcCtD
Acetylcysteine—Pruritus—Fosphenytoin—epilepsy syndrome	6.7e-05	0.000845	CcSEcCtD
Acetylcysteine—Hypersensitivity—Diazepam—epilepsy syndrome	6.69e-05	0.000844	CcSEcCtD
Acetylcysteine—Dyspepsia—Lamotrigine—epilepsy syndrome	6.69e-05	0.000844	CcSEcCtD
Acetylcysteine—Urticaria—Clonazepam—epilepsy syndrome	6.59e-05	0.000831	CcSEcCtD
Acetylcysteine—Dizziness—Midazolam—epilepsy syndrome	6.57e-05	0.000828	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	6.56e-05	0.000828	CcSEcCtD
Acetylcysteine—Body temperature increased—Clonazepam—epilepsy syndrome	6.56e-05	0.000827	CcSEcCtD
Acetylcysteine—Urticaria—Phenytoin—epilepsy syndrome	6.54e-05	0.000825	CcSEcCtD
Acetylcysteine—Cardiac disorder—Gabapentin—epilepsy syndrome	6.54e-05	0.000825	CcSEcCtD
Acetylcysteine—Pruritus—Vigabatrin—epilepsy syndrome	6.53e-05	0.000823	CcSEcCtD
Acetylcysteine—Body temperature increased—Phenytoin—epilepsy syndrome	6.51e-05	0.000821	CcSEcCtD
Acetylcysteine—Urticaria—Oxcarbazepine—epilepsy syndrome	6.51e-05	0.000821	CcSEcCtD
Acetylcysteine—Nausea—Acetazolamide—epilepsy syndrome	6.49e-05	0.000819	CcSEcCtD
Acetylcysteine—Dizziness—Levetiracetam—epilepsy syndrome	6.48e-05	0.000818	CcSEcCtD
Acetylcysteine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	6.48e-05	0.000817	CcSEcCtD
Acetylcysteine—Cough—Valproic Acid—epilepsy syndrome	6.46e-05	0.000814	CcSEcCtD
Acetylcysteine—Vomiting—Propofol—epilepsy syndrome	6.45e-05	0.000814	CcSEcCtD
Acetylcysteine—Stomatitis—Topiramate—epilepsy syndrome	6.44e-05	0.000812	CcSEcCtD
Acetylcysteine—Pruritus—Diazepam—epilepsy syndrome	6.43e-05	0.000811	CcSEcCtD
Acetylcysteine—Rash—Propofol—epilepsy syndrome	6.4e-05	0.000807	CcSEcCtD
Acetylcysteine—Dermatitis—Propofol—epilepsy syndrome	6.39e-05	0.000806	CcSEcCtD
Acetylcysteine—Immune system disorder—Gabapentin—epilepsy syndrome	6.36e-05	0.000803	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Gabapentin—epilepsy syndrome	6.35e-05	0.000801	CcSEcCtD
Acetylcysteine—Hypersensitivity—Zonisamide—epilepsy syndrome	6.34e-05	0.0008	CcSEcCtD
Acetylcysteine—Vomiting—Midazolam—epilepsy syndrome	6.31e-05	0.000796	CcSEcCtD
Acetylcysteine—Rash—Midazolam—epilepsy syndrome	6.26e-05	0.00079	CcSEcCtD
Acetylcysteine—Dizziness—Fosphenytoin—epilepsy syndrome	6.26e-05	0.000789	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.26e-05	0.000789	CcSEcCtD
Acetylcysteine—Dermatitis—Midazolam—epilepsy syndrome	6.26e-05	0.000789	CcSEcCtD
Acetylcysteine—Urticaria—Carbamazepine—epilepsy syndrome	6.25e-05	0.000788	CcSEcCtD
Acetylcysteine—Vomiting—Levetiracetam—epilepsy syndrome	6.23e-05	0.000786	CcSEcCtD
Acetylcysteine—Pruritus—Felbamate—epilepsy syndrome	6.22e-05	0.000784	CcSEcCtD
Acetylcysteine—Body temperature increased—Carbamazepine—epilepsy syndrome	6.22e-05	0.000784	CcSEcCtD
Acetylcysteine—Rash—Levetiracetam—epilepsy syndrome	6.18e-05	0.00078	CcSEcCtD
Acetylcysteine—Dermatitis—Levetiracetam—epilepsy syndrome	6.18e-05	0.000779	CcSEcCtD
Acetylcysteine—Erythema—Gabapentin—epilepsy syndrome	6.13e-05	0.000774	CcSEcCtD
Acetylcysteine—Angioedema—Pregabalin—epilepsy syndrome	6.11e-05	0.000771	CcSEcCtD
Acetylcysteine—Hypersensitivity—Clonazepam—epilepsy syndrome	6.11e-05	0.000771	CcSEcCtD
Acetylcysteine—Dizziness—Vigabatrin—epilepsy syndrome	6.1e-05	0.000769	CcSEcCtD
Acetylcysteine—Pruritus—Zonisamide—epilepsy syndrome	6.09e-05	0.000768	CcSEcCtD
Acetylcysteine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.07e-05	0.000765	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.04e-05	0.000762	CcSEcCtD
Acetylcysteine—Oedema—Valproic Acid—epilepsy syndrome	6.04e-05	0.000762	CcSEcCtD
Acetylcysteine—Urticaria—Lamotrigine—epilepsy syndrome	6.04e-05	0.000761	CcSEcCtD
Acetylcysteine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.04e-05	0.000761	CcSEcCtD
Acetylcysteine—Nausea—Propofol—epilepsy syndrome	6.03e-05	0.00076	CcSEcCtD
Acetylcysteine—Vomiting—Fosphenytoin—epilepsy syndrome	6.02e-05	0.000759	CcSEcCtD
Acetylcysteine—Body temperature increased—Lamotrigine—epilepsy syndrome	6.01e-05	0.000758	CcSEcCtD
Acetylcysteine—Dizziness—Diazepam—epilepsy syndrome	6.01e-05	0.000758	CcSEcCtD
Acetylcysteine—Syncope—Pregabalin—epilepsy syndrome	6e-05	0.000757	CcSEcCtD
Acetylcysteine—Rash—Fosphenytoin—epilepsy syndrome	5.97e-05	0.000753	CcSEcCtD
Acetylcysteine—Dermatitis—Fosphenytoin—epilepsy syndrome	5.96e-05	0.000752	CcSEcCtD
Acetylcysteine—Nausea—Midazolam—epilepsy syndrome	5.9e-05	0.000744	CcSEcCtD
Acetylcysteine—Tachycardia—Valproic Acid—epilepsy syndrome	5.89e-05	0.000743	CcSEcCtD
Acetylcysteine—Pharyngitis—Topiramate—epilepsy syndrome	5.88e-05	0.000742	CcSEcCtD
Acetylcysteine—Loss of consciousness—Pregabalin—epilepsy syndrome	5.88e-05	0.000742	CcSEcCtD
Acetylcysteine—Pruritus—Clonazepam—epilepsy syndrome	5.87e-05	0.00074	CcSEcCtD
Acetylcysteine—Vomiting—Vigabatrin—epilepsy syndrome	5.87e-05	0.00074	CcSEcCtD
Acetylcysteine—Skin disorder—Valproic Acid—epilepsy syndrome	5.87e-05	0.00074	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.84e-05	0.000736	CcSEcCtD
Acetylcysteine—Cough—Pregabalin—epilepsy syndrome	5.84e-05	0.000736	CcSEcCtD
Acetylcysteine—Pruritus—Phenytoin—epilepsy syndrome	5.83e-05	0.000735	CcSEcCtD
Acetylcysteine—Nausea—Levetiracetam—epilepsy syndrome	5.82e-05	0.000735	CcSEcCtD
Acetylcysteine—Rash—Vigabatrin—epilepsy syndrome	5.82e-05	0.000734	CcSEcCtD
Acetylcysteine—Dizziness—Felbamate—epilepsy syndrome	5.81e-05	0.000733	CcSEcCtD
Acetylcysteine—Dermatitis—Vigabatrin—epilepsy syndrome	5.81e-05	0.000733	CcSEcCtD
Acetylcysteine—Pruritus—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000731	CcSEcCtD
Acetylcysteine—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.79e-05	0.000731	CcSEcCtD
Acetylcysteine—Vomiting—Diazepam—epilepsy syndrome	5.77e-05	0.000728	CcSEcCtD
Acetylcysteine—Rash—Diazepam—epilepsy syndrome	5.73e-05	0.000722	CcSEcCtD
Acetylcysteine—Dermatitis—Diazepam—epilepsy syndrome	5.72e-05	0.000722	CcSEcCtD
Acetylcysteine—Dizziness—Zonisamide—epilepsy syndrome	5.69e-05	0.000718	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.66e-05	0.000713	CcSEcCtD
Acetylcysteine—Hypotension—Valproic Acid—epilepsy syndrome	5.64e-05	0.000712	CcSEcCtD
Acetylcysteine—Nausea—Fosphenytoin—epilepsy syndrome	5.62e-05	0.000709	CcSEcCtD
Acetylcysteine—Angioedema—Gabapentin—epilepsy syndrome	5.6e-05	0.000707	CcSEcCtD
Acetylcysteine—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.6e-05	0.000706	CcSEcCtD
Acetylcysteine—Vomiting—Felbamate—epilepsy syndrome	5.59e-05	0.000705	CcSEcCtD
Acetylcysteine—Pruritus—Carbamazepine—epilepsy syndrome	5.56e-05	0.000702	CcSEcCtD
Acetylcysteine—Rash—Felbamate—epilepsy syndrome	5.54e-05	0.000699	CcSEcCtD
Acetylcysteine—Dermatitis—Felbamate—epilepsy syndrome	5.54e-05	0.000698	CcSEcCtD
Acetylcysteine—Cardiac disorder—Topiramate—epilepsy syndrome	5.5e-05	0.000694	CcSEcCtD
Acetylcysteine—Flushing—Topiramate—epilepsy syndrome	5.5e-05	0.000694	CcSEcCtD
Acetylcysteine—Syncope—Gabapentin—epilepsy syndrome	5.5e-05	0.000694	CcSEcCtD
Acetylcysteine—Dizziness—Clonazepam—epilepsy syndrome	5.48e-05	0.000692	CcSEcCtD
Acetylcysteine—Nausea—Vigabatrin—epilepsy syndrome	5.48e-05	0.000691	CcSEcCtD
Acetylcysteine—Vomiting—Zonisamide—epilepsy syndrome	5.47e-05	0.00069	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.46e-05	0.000689	CcSEcCtD
Acetylcysteine—Oedema—Pregabalin—epilepsy syndrome	5.46e-05	0.000689	CcSEcCtD
Acetylcysteine—Dizziness—Phenytoin—epilepsy syndrome	5.45e-05	0.000687	CcSEcCtD
Acetylcysteine—Rash—Zonisamide—epilepsy syndrome	5.43e-05	0.000684	CcSEcCtD
Acetylcysteine—Dermatitis—Zonisamide—epilepsy syndrome	5.42e-05	0.000684	CcSEcCtD
Acetylcysteine—Dizziness—Oxcarbazepine—epilepsy syndrome	5.42e-05	0.000683	CcSEcCtD
Acetylcysteine—Nausea—Diazepam—epilepsy syndrome	5.39e-05	0.00068	CcSEcCtD
Acetylcysteine—Loss of consciousness—Gabapentin—epilepsy syndrome	5.39e-05	0.00068	CcSEcCtD
Acetylcysteine—Dyspnoea—Valproic Acid—epilepsy syndrome	5.38e-05	0.000679	CcSEcCtD
Acetylcysteine—Angiopathy—Topiramate—epilepsy syndrome	5.38e-05	0.000678	CcSEcCtD
Acetylcysteine—Pruritus—Lamotrigine—epilepsy syndrome	5.38e-05	0.000678	CcSEcCtD
Acetylcysteine—Shock—Pregabalin—epilepsy syndrome	5.37e-05	0.000677	CcSEcCtD
Acetylcysteine—Somnolence—Valproic Acid—epilepsy syndrome	5.37e-05	0.000677	CcSEcCtD
Acetylcysteine—Immune system disorder—Topiramate—epilepsy syndrome	5.35e-05	0.000675	CcSEcCtD
Acetylcysteine—Cough—Gabapentin—epilepsy syndrome	5.35e-05	0.000675	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Topiramate—epilepsy syndrome	5.34e-05	0.000674	CcSEcCtD
Acetylcysteine—Tachycardia—Pregabalin—epilepsy syndrome	5.33e-05	0.000672	CcSEcCtD
Acetylcysteine—Dyspepsia—Valproic Acid—epilepsy syndrome	5.32e-05	0.00067	CcSEcCtD
Acetylcysteine—Skin disorder—Pregabalin—epilepsy syndrome	5.3e-05	0.000669	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.28e-05	0.000666	CcSEcCtD
Acetylcysteine—Vomiting—Clonazepam—epilepsy syndrome	5.27e-05	0.000665	CcSEcCtD
Acetylcysteine—Vomiting—Phenytoin—epilepsy syndrome	5.24e-05	0.000661	CcSEcCtD
Acetylcysteine—Rash—Clonazepam—epilepsy syndrome	5.23e-05	0.00066	CcSEcCtD
Acetylcysteine—Dermatitis—Clonazepam—epilepsy syndrome	5.22e-05	0.000659	CcSEcCtD
Acetylcysteine—Nausea—Felbamate—epilepsy syndrome	5.22e-05	0.000659	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.21e-05	0.000658	CcSEcCtD
Acetylcysteine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.000657	CcSEcCtD
Acetylcysteine—Dizziness—Carbamazepine—epilepsy syndrome	5.2e-05	0.000656	CcSEcCtD
Acetylcysteine—Rash—Phenytoin—epilepsy syndrome	5.19e-05	0.000655	CcSEcCtD
Acetylcysteine—Dermatitis—Phenytoin—epilepsy syndrome	5.19e-05	0.000655	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.19e-05	0.000654	CcSEcCtD
Acetylcysteine—Rash—Oxcarbazepine—epilepsy syndrome	5.17e-05	0.000652	CcSEcCtD
Acetylcysteine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.16e-05	0.000651	CcSEcCtD
Acetylcysteine—Erythema—Topiramate—epilepsy syndrome	5.16e-05	0.000651	CcSEcCtD
Acetylcysteine—Nausea—Zonisamide—epilepsy syndrome	5.11e-05	0.000645	CcSEcCtD
Acetylcysteine—Hypotension—Pregabalin—epilepsy syndrome	5.1e-05	0.000643	CcSEcCtD
Acetylcysteine—Dizziness—Lamotrigine—epilepsy syndrome	5.02e-05	0.000634	CcSEcCtD
Acetylcysteine—Oedema—Gabapentin—epilepsy syndrome	5.01e-05	0.000631	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.01e-05	0.000631	CcSEcCtD
Acetylcysteine—Vomiting—Carbamazepine—epilepsy syndrome	5e-05	0.000631	CcSEcCtD
Acetylcysteine—Rash—Carbamazepine—epilepsy syndrome	4.96e-05	0.000625	CcSEcCtD
Acetylcysteine—Dermatitis—Carbamazepine—epilepsy syndrome	4.95e-05	0.000625	CcSEcCtD
Acetylcysteine—Nausea—Clonazepam—epilepsy syndrome	4.93e-05	0.000621	CcSEcCtD
Acetylcysteine—Shock—Gabapentin—epilepsy syndrome	4.92e-05	0.000621	CcSEcCtD
Acetylcysteine—Nausea—Phenytoin—epilepsy syndrome	4.89e-05	0.000617	CcSEcCtD
Acetylcysteine—Tachycardia—Gabapentin—epilepsy syndrome	4.89e-05	0.000616	CcSEcCtD
Acetylcysteine—Dyspnoea—Pregabalin—epilepsy syndrome	4.87e-05	0.000614	CcSEcCtD
Acetylcysteine—Nausea—Oxcarbazepine—epilepsy syndrome	4.87e-05	0.000614	CcSEcCtD
Acetylcysteine—Skin disorder—Gabapentin—epilepsy syndrome	4.86e-05	0.000613	CcSEcCtD
Acetylcysteine—Somnolence—Pregabalin—epilepsy syndrome	4.85e-05	0.000612	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.84e-05	0.00061	CcSEcCtD
Acetylcysteine—Vomiting—Lamotrigine—epilepsy syndrome	4.83e-05	0.000609	CcSEcCtD
Acetylcysteine—Urticaria—Valproic Acid—epilepsy syndrome	4.8e-05	0.000605	CcSEcCtD
Acetylcysteine—Rash—Lamotrigine—epilepsy syndrome	4.79e-05	0.000604	CcSEcCtD
Acetylcysteine—Dermatitis—Lamotrigine—epilepsy syndrome	4.79e-05	0.000604	CcSEcCtD
Acetylcysteine—Body temperature increased—Valproic Acid—epilepsy syndrome	4.77e-05	0.000602	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.71e-05	0.000594	CcSEcCtD
Acetylcysteine—Hypotension—Gabapentin—epilepsy syndrome	4.68e-05	0.00059	CcSEcCtD
Acetylcysteine—Nausea—Carbamazepine—epilepsy syndrome	4.67e-05	0.000589	CcSEcCtD
Acetylcysteine—Syncope—Topiramate—epilepsy syndrome	4.63e-05	0.000584	CcSEcCtD
Acetylcysteine—Loss of consciousness—Topiramate—epilepsy syndrome	4.54e-05	0.000572	CcSEcCtD
Acetylcysteine—Nausea—Lamotrigine—epilepsy syndrome	4.51e-05	0.000569	CcSEcCtD
Acetylcysteine—Cough—Topiramate—epilepsy syndrome	4.5e-05	0.000568	CcSEcCtD
Acetylcysteine—Dyspnoea—Gabapentin—epilepsy syndrome	4.46e-05	0.000563	CcSEcCtD
Acetylcysteine—Somnolence—Gabapentin—epilepsy syndrome	4.45e-05	0.000561	CcSEcCtD
Acetylcysteine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.45e-05	0.000561	CcSEcCtD
Acetylcysteine—Dyspepsia—Gabapentin—epilepsy syndrome	4.41e-05	0.000556	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.36e-05	0.00055	CcSEcCtD
Acetylcysteine—Urticaria—Pregabalin—epilepsy syndrome	4.34e-05	0.000547	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.32e-05	0.000545	CcSEcCtD
Acetylcysteine—Body temperature increased—Pregabalin—epilepsy syndrome	4.32e-05	0.000544	CcSEcCtD
Acetylcysteine—Pruritus—Valproic Acid—epilepsy syndrome	4.27e-05	0.000539	CcSEcCtD
Acetylcysteine—Oedema—Topiramate—epilepsy syndrome	4.21e-05	0.000531	CcSEcCtD
Acetylcysteine—Shock—Topiramate—epilepsy syndrome	4.14e-05	0.000523	CcSEcCtD
Acetylcysteine—Tachycardia—Topiramate—epilepsy syndrome	4.11e-05	0.000518	CcSEcCtD
Acetylcysteine—Skin disorder—Topiramate—epilepsy syndrome	4.09e-05	0.000516	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.07e-05	0.000514	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.02e-05	0.000507	CcSEcCtD
Acetylcysteine—Dizziness—Valproic Acid—epilepsy syndrome	3.99e-05	0.000504	CcSEcCtD
Acetylcysteine—Urticaria—Gabapentin—epilepsy syndrome	3.98e-05	0.000502	CcSEcCtD
Acetylcysteine—Body temperature increased—Gabapentin—epilepsy syndrome	3.96e-05	0.000499	CcSEcCtD
Acetylcysteine—Hypotension—Topiramate—epilepsy syndrome	3.94e-05	0.000496	CcSEcCtD
Acetylcysteine—Pruritus—Pregabalin—epilepsy syndrome	3.86e-05	0.000487	CcSEcCtD
Acetylcysteine—Vomiting—Valproic Acid—epilepsy syndrome	3.84e-05	0.000484	CcSEcCtD
Acetylcysteine—Rash—Valproic Acid—epilepsy syndrome	3.81e-05	0.00048	CcSEcCtD
Acetylcysteine—Dermatitis—Valproic Acid—epilepsy syndrome	3.8e-05	0.00048	CcSEcCtD
Acetylcysteine—Dyspnoea—Topiramate—epilepsy syndrome	3.75e-05	0.000474	CcSEcCtD
Acetylcysteine—Somnolence—Topiramate—epilepsy syndrome	3.74e-05	0.000472	CcSEcCtD
Acetylcysteine—Dyspepsia—Topiramate—epilepsy syndrome	3.71e-05	0.000468	CcSEcCtD
Acetylcysteine—Hypersensitivity—Gabapentin—epilepsy syndrome	3.69e-05	0.000465	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.64e-05	0.000459	CcSEcCtD
Acetylcysteine—Dizziness—Pregabalin—epilepsy syndrome	3.61e-05	0.000455	CcSEcCtD
Acetylcysteine—Nausea—Valproic Acid—epilepsy syndrome	3.59e-05	0.000452	CcSEcCtD
Acetylcysteine—Pruritus—Gabapentin—epilepsy syndrome	3.54e-05	0.000447	CcSEcCtD
Acetylcysteine—Vomiting—Pregabalin—epilepsy syndrome	3.47e-05	0.000438	CcSEcCtD
Acetylcysteine—Rash—Pregabalin—epilepsy syndrome	3.44e-05	0.000434	CcSEcCtD
Acetylcysteine—Dermatitis—Pregabalin—epilepsy syndrome	3.44e-05	0.000434	CcSEcCtD
Acetylcysteine—Urticaria—Topiramate—epilepsy syndrome	3.35e-05	0.000422	CcSEcCtD
Acetylcysteine—Body temperature increased—Topiramate—epilepsy syndrome	3.33e-05	0.00042	CcSEcCtD
Acetylcysteine—Dizziness—Gabapentin—epilepsy syndrome	3.31e-05	0.000418	CcSEcCtD
Acetylcysteine—Nausea—Pregabalin—epilepsy syndrome	3.24e-05	0.000409	CcSEcCtD
Acetylcysteine—Vomiting—Gabapentin—epilepsy syndrome	3.18e-05	0.000401	CcSEcCtD
Acetylcysteine—Rash—Gabapentin—epilepsy syndrome	3.16e-05	0.000398	CcSEcCtD
Acetylcysteine—Dermatitis—Gabapentin—epilepsy syndrome	3.15e-05	0.000398	CcSEcCtD
Acetylcysteine—Hypersensitivity—Topiramate—epilepsy syndrome	3.1e-05	0.000391	CcSEcCtD
Acetylcysteine—Pruritus—Topiramate—epilepsy syndrome	2.98e-05	0.000376	CcSEcCtD
Acetylcysteine—Nausea—Gabapentin—epilepsy syndrome	2.97e-05	0.000375	CcSEcCtD
Acetylcysteine—Dizziness—Topiramate—epilepsy syndrome	2.78e-05	0.000351	CcSEcCtD
Acetylcysteine—Vomiting—Topiramate—epilepsy syndrome	2.68e-05	0.000338	CcSEcCtD
Acetylcysteine—Rash—Topiramate—epilepsy syndrome	2.66e-05	0.000335	CcSEcCtD
Acetylcysteine—Dermatitis—Topiramate—epilepsy syndrome	2.65e-05	0.000335	CcSEcCtD
Acetylcysteine—Nausea—Topiramate—epilepsy syndrome	2.5e-05	0.000316	CcSEcCtD
Acetylcysteine—CHUK—Disease—NOS1—epilepsy syndrome	2.72e-06	3.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CHRM3—epilepsy syndrome	2.72e-06	3.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP2—epilepsy syndrome	2.72e-06	3.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GRM5—epilepsy syndrome	2.72e-06	3.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—epilepsy syndrome	2.72e-06	3.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40—epilepsy syndrome	2.71e-06	3.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.7e-06	3.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PRKCB—epilepsy syndrome	2.66e-06	3.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—epilepsy syndrome	2.66e-06	3.15e-05	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—epilepsy syndrome	2.66e-06	3.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRH3—epilepsy syndrome	2.63e-06	3.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CX3CR1—epilepsy syndrome	2.61e-06	3.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—epilepsy syndrome	2.61e-06	3.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HBEGF—epilepsy syndrome	2.6e-06	3.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—OPRM1—epilepsy syndrome	2.59e-06	3.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CX3CL1—epilepsy syndrome	2.56e-06	3.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CHRM2—epilepsy syndrome	2.56e-06	3.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BDKRB1—epilepsy syndrome	2.56e-06	3.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HBEGF—epilepsy syndrome	2.55e-06	3.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—S100B—epilepsy syndrome	2.55e-06	3.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT3—epilepsy syndrome	2.55e-06	3.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	2.54e-06	3.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FOS—epilepsy syndrome	2.53e-06	2.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SOCS3—epilepsy syndrome	2.53e-06	2.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDC42—epilepsy syndrome	2.52e-06	2.98e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—epilepsy syndrome	2.51e-06	2.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT3—epilepsy syndrome	2.51e-06	2.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ADAM10—epilepsy syndrome	2.49e-06	2.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GABBR1—epilepsy syndrome	2.49e-06	2.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CASP8—epilepsy syndrome	2.47e-06	2.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FGF2—epilepsy syndrome	2.46e-06	2.91e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	2.46e-06	2.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR3—epilepsy syndrome	2.45e-06	2.9e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—epilepsy syndrome	2.45e-06	2.9e-05	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—epilepsy syndrome	2.41e-06	2.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—epilepsy syndrome	2.41e-06	2.85e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	2.39e-06	2.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRH3—epilepsy syndrome	2.39e-06	2.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NPY—epilepsy syndrome	2.39e-06	2.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ATP2A2—epilepsy syndrome	2.39e-06	2.82e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	2.38e-06	2.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FGF2—epilepsy syndrome	2.36e-06	2.8e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.36e-06	2.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—OPRM1—epilepsy syndrome	2.35e-06	2.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL2—epilepsy syndrome	2.34e-06	2.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDC42—epilepsy syndrome	2.33e-06	2.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—S100B—epilepsy syndrome	2.31e-06	2.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL18—epilepsy syndrome	2.3e-06	2.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL3—epilepsy syndrome	2.3e-06	2.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CRH—epilepsy syndrome	2.3e-06	2.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—OXT—epilepsy syndrome	2.3e-06	2.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL2—epilepsy syndrome	2.3e-06	2.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HSPB1—epilepsy syndrome	2.3e-06	2.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SOCS3—epilepsy syndrome	2.29e-06	2.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDC42—epilepsy syndrome	2.29e-06	2.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—RELA—epilepsy syndrome	2.29e-06	2.7e-05	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.25e-06	2.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FYN—epilepsy syndrome	2.24e-06	2.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MTOR—epilepsy syndrome	2.24e-06	2.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FGF2—epilepsy syndrome	2.23e-06	2.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MEF2C—epilepsy syndrome	2.23e-06	2.64e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR3—epilepsy syndrome	2.22e-06	2.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—RELA—epilepsy syndrome	2.2e-06	2.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NPY—epilepsy syndrome	2.16e-06	2.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ATP2A2—epilepsy syndrome	2.16e-06	2.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—YWHAZ—epilepsy syndrome	2.16e-06	2.55e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.15e-06	2.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MTOR—epilepsy syndrome	2.15e-06	2.55e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	2.15e-06	2.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FGF2—epilepsy syndrome	2.14e-06	2.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTK2B—epilepsy syndrome	2.14e-06	2.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSC1—epilepsy syndrome	2.14e-06	2.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HES1—epilepsy syndrome	2.13e-06	2.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2—epilepsy syndrome	2.12e-06	2.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL18—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HSPB1—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL2—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—OXT—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CRH—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL3—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTRK2—epilepsy syndrome	2.08e-06	2.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SST—epilepsy syndrome	2.08e-06	2.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR2—epilepsy syndrome	2.08e-06	2.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—RELA—epilepsy syndrome	2.07e-06	2.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FYN—epilepsy syndrome	2.07e-06	2.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—H2AFX—epilepsy syndrome	2.06e-06	2.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—DUSP6—epilepsy syndrome	2.06e-06	2.44e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.05e-06	2.42e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADRA2A—epilepsy syndrome	2.04e-06	2.41e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	2.04e-06	2.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FYN—epilepsy syndrome	2.03e-06	2.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MTOR—epilepsy syndrome	2.03e-06	2.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLAT—epilepsy syndrome	2.03e-06	2.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MEF2C—epilepsy syndrome	2.02e-06	2.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—JUN—epilepsy syndrome	2e-06	2.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—YWHAZ—epilepsy syndrome	1.99e-06	2.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—RELA—epilepsy syndrome	1.99e-06	2.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BDKRB2—epilepsy syndrome	1.96e-06	2.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL12—epilepsy syndrome	1.96e-06	2.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—epilepsy syndrome	1.96e-06	2.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—YWHAZ—epilepsy syndrome	1.96e-06	2.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MTOR—epilepsy syndrome	1.95e-06	2.31e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	1.94e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTK2B—epilepsy syndrome	1.94e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSC1—epilepsy syndrome	1.94e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TSC2—epilepsy syndrome	1.93e-06	2.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—epilepsy syndrome	1.93e-06	2.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CNR1—epilepsy syndrome	1.92e-06	2.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUNB—epilepsy syndrome	1.92e-06	2.27e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	1.92e-06	2.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CCR5—epilepsy syndrome	1.92e-06	2.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLCB1—epilepsy syndrome	1.91e-06	2.27e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TH—epilepsy syndrome	1.91e-06	2.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTRK2—epilepsy syndrome	1.89e-06	2.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SST—epilepsy syndrome	1.89e-06	2.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR2—epilepsy syndrome	1.89e-06	2.23e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.88e-06	2.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HTR7—epilepsy syndrome	1.87e-06	2.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—DUSP6—epilepsy syndrome	1.87e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—epilepsy syndrome	1.87e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADRA2A—epilepsy syndrome	1.85e-06	2.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLAT—epilepsy syndrome	1.84e-06	2.18e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—epilepsy syndrome	1.82e-06	2.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HBEGF—epilepsy syndrome	1.82e-06	2.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—JUN—epilepsy syndrome	1.82e-06	2.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—epilepsy syndrome	1.8e-06	2.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT3—epilepsy syndrome	1.79e-06	2.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TSC2—epilepsy syndrome	1.78e-06	2.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PRKCB—epilepsy syndrome	1.78e-06	2.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL12—epilepsy syndrome	1.78e-06	2.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BDKRB2—epilepsy syndrome	1.78e-06	2.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—epilepsy syndrome	1.77e-06	2.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6ST—epilepsy syndrome	1.77e-06	2.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TSC2—epilepsy syndrome	1.75e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—epilepsy syndrome	1.75e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADAM10—epilepsy syndrome	1.74e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—epilepsy syndrome	1.74e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUNB—epilepsy syndrome	1.74e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR1—epilepsy syndrome	1.74e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLCB1—epilepsy syndrome	1.74e-06	2.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—epilepsy syndrome	1.72e-06	2.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HTR7—epilepsy syndrome	1.7e-06	2.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HBEGF—epilepsy syndrome	1.65e-06	1.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—S100B—epilepsy syndrome	1.65e-06	1.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6ST—epilepsy syndrome	1.64e-06	1.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SOCS3—epilepsy syndrome	1.63e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDC42—epilepsy syndrome	1.63e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—epilepsy syndrome	1.63e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FOS—epilepsy syndrome	1.62e-06	1.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS2—epilepsy syndrome	1.62e-06	1.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT3—epilepsy syndrome	1.62e-06	1.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PRKCB—epilepsy syndrome	1.61e-06	1.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6ST—epilepsy syndrome	1.61e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	1.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CASP8—epilepsy syndrome	1.59e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADAM10—epilepsy syndrome	1.58e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AVP—epilepsy syndrome	1.58e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAT—epilepsy syndrome	1.58e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—epilepsy syndrome	1.56e-06	1.85e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—S100B—epilepsy syndrome	1.5e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HES1—epilepsy syndrome	1.49e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SOCS3—epilepsy syndrome	1.48e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDC42—epilepsy syndrome	1.48e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOS—epilepsy syndrome	1.47e-06	1.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FYN—epilepsy syndrome	1.45e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—H2AFX—epilepsy syndrome	1.45e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MEF2C—epilepsy syndrome	1.44e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—epilepsy syndrome	1.44e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGF2—epilepsy syndrome	1.43e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AVP—epilepsy syndrome	1.43e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	1.43e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—YWHAZ—epilepsy syndrome	1.39e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—epilepsy syndrome	1.39e-06	1.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NGF—epilepsy syndrome	1.38e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—epilepsy syndrome	1.36e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HES1—epilepsy syndrome	1.35e-06	1.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR5—epilepsy syndrome	1.34e-06	1.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RELA—epilepsy syndrome	1.33e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGF2—epilepsy syndrome	1.32e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FYN—epilepsy syndrome	1.32e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HTR2A—epilepsy syndrome	1.31e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—H2AFX—epilepsy syndrome	1.31e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MEF2C—epilepsy syndrome	1.31e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—epilepsy syndrome	1.31e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGF2—epilepsy syndrome	1.3e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—YWHAZ—epilepsy syndrome	1.26e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NGF—epilepsy syndrome	1.25e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AGT—epilepsy syndrome	1.25e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AGT—epilepsy syndrome	1.25e-06	1.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—epilepsy syndrome	1.23e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—epilepsy syndrome	1.22e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR5—epilepsy syndrome	1.22e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RELA—epilepsy syndrome	1.21e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—epilepsy syndrome	1.21e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—epilepsy syndrome	1.2e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—epilepsy syndrome	1.2e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—epilepsy syndrome	1.19e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HTR2A—epilepsy syndrome	1.19e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—epilepsy syndrome	1.18e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—epilepsy syndrome	1.17e-06	1.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSC2—epilepsy syndrome	1.13e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGT—epilepsy syndrome	1.13e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—epilepsy syndrome	1.12e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—epilepsy syndrome	1.11e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—epilepsy syndrome	1.09e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—epilepsy syndrome	1.08e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—epilepsy syndrome	1.07e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—epilepsy syndrome	1.06e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—POMC—epilepsy syndrome	1.05e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—epilepsy syndrome	1.05e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCB—epilepsy syndrome	1.04e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6ST—epilepsy syndrome	1.04e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—epilepsy syndrome	1.01e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—epilepsy syndrome	9.72e-07	1.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—epilepsy syndrome	9.66e-07	1.14e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—epilepsy syndrome	9.59e-07	1.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—POMC—epilepsy syndrome	9.51e-07	1.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—epilepsy syndrome	9.49e-07	1.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—epilepsy syndrome	9.3e-07	1.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGF2—epilepsy syndrome	9.27e-07	1.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RELA—epilepsy syndrome	8.61e-07	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—epilepsy syndrome	8.44e-07	9.99e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF2—epilepsy syndrome	8.41e-07	9.95e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	8.39e-07	9.93e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RELA—epilepsy syndrome	7.81e-07	9.23e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—epilepsy syndrome	7.76e-07	9.19e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—epilepsy syndrome	7.65e-07	9.06e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—epilepsy syndrome	7.54e-07	8.92e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—epilepsy syndrome	7.34e-07	8.68e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—epilepsy syndrome	7.04e-07	8.33e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—epilepsy syndrome	6.84e-07	8.09e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—epilepsy syndrome	6.76e-07	8e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—epilepsy syndrome	6.65e-07	7.87e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—epilepsy syndrome	6.59e-07	7.79e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—epilepsy syndrome	6.5e-07	7.69e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—epilepsy syndrome	6.13e-07	7.26e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—epilepsy syndrome	6e-07	7.1e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—epilepsy syndrome	5.97e-07	7.07e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—epilepsy syndrome	5.9e-07	6.98e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	4.22e-07	4.99e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—epilepsy syndrome	4.2e-07	4.97e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—epilepsy syndrome	3.81e-07	4.51e-06	CbGpPWpGaD
